Fidson Healthcare has called on stakeholders in the pharmaceutical industry to support the National Agency for Food and Drugs Administration and Control (NAFDAC) on the fight against fake drugs in the country.

Operations Director of Fidson Healthcare, Mr. Abiola Adebayo who made the call recently, said "The fight against drug counterfeiting has affected the health and image of the country for so many years now, irrespective of the tireless efforts put in place by NAFDAC."

The effects of drug counterfeiting on the country are devastating, affecting the industry and economy of the country, he said, while maintaining that it is imperative to see that the on-going campaign is not left to NAFDAC alone, since the challenge of fake drugs is neither a NAFDAC problem nor that of the pharmaceutical industry.

He said: "It has become a serious national issue because it has to do with human lives, hence everybody, including pharmaceutical firms must join hands with NAFDAC in this fight."